Fluconazole Prophylaxis in HIV Disease, Revisited

Samuel A. Bozzette

ResearchPosted on rand.org 2005Published in: Clinical Infectious Diseases, v. 41, no. 15, Editorial Commentary, Nov. 2005, p. 1481-1482

Editorial comment on a study of the use of fluconazole prophylaxis for mucosal candidal infection in HIV disease, and the question of emerging drug resistance associated with its use.

Read More

Topics

Document Details

  • Copyright: University of Chicago Press
  • Availability: Non-RAND
  • Year: 2005
  • Pages: 2
  • Document Number: EP-200511-07

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.